Radformation and Icon Group Partner to Deploy Offline Adaptive Assessment Across Clinical Network

Automated In-Vivo Dose Monitoring Empowers Clinicians to Make Informed Decisions

New York, NY - September 29, 2025

Radformation Inc, a leading provider of intelligent automation solutions for radiation oncology, today announced a new collaboration with Icon Group, a leading global integrated cancer care provider, to implement Radformation's Offline Adaptive Assessment solution across its clinical network. This initiative represents an important step in the ongoing partnership and bringing practical, scalable adaptive radiotherapy workflows to patients and clinics globally.

Daily anatomical changes can impact the accuracy of treatment delivery in radiotherapy. While adaptive radiotherapy provides a way to respond to these changes, existing monitoring processes are often complex and resource-intensive. Radformation's Offline Adaptive Assessment solution within ChartCheck simplifies this workflow, enabling clinicians to evaluate changes fraction by fraction with efficiency and confidence. With in-vivo calculation-based verification, the approach creates a closed feedback loop, supporting proactive identification of when to adapt and confirming that each treatment is delivered as intended.

Importantly, the solution builds upon Radformation's established suite of automation tools including deformable image registration, contour propagation, plan evaluation, secondary dose calculation and treatment monitoring - software already trusted by thousands of clinics worldwide. By extending these familiar and widely adopted workflows into the adaptive space, Radformation offers a seamless pathway for clinics to expand their use of automation without adding to the clinical workload.

"At Icon, we are focused on delivering innovative and personalised care that reflects each patient's needs throughout their treatment," said Trent Aland, Executive Manager, Clinical Care at Icon Group. "Radformation's Offline Adaptive Assessment solution will offer our clinicians clearer insights and efficiency in assessing daily changes and evaluating their cumulative impact on the entire course of treatment, giving them the confidence to make informed decisions for every fraction."

This latest initiative builds on an established relationship between Icon and Radformation. Icon already relies on Radformation's automation software, including AutoContour for AI-driven contouring and RadMachine for machine quality assurance - tools deployed across its extensive network to support precision and efficiency in daily workflows. With this collaboration, Icon and Radformation are deepening a trusted partnership that continues to grow with the needs of modern radiotherapy.

"Radformation is committed to redefining precision in radiation oncology by making adaptive assessment accessible, efficient, proven, and scalable," said Kurt Sysock, CEO of Radformation. "This initiative with Icon demonstrates how automation investment already in use around the world can be expanded to support adaptive radiotherapy, amplifying their clinical impact."

ChartCheck Adaptive: Offline Adaptive Assessment is pending USFDA 510(k) clearance. Not available in all markets.

_{The user interface displays daily tracking of structure constraints and goals, with accumulated dose monitored at each fraction to confirm constraints are met. Radformation's Offline Adaptive Assessment provides clinicians with clarity on when treatment adaptation may be required.}

Media Contact
Melanie Benton
Director of Marketing
Radformation
mbenton@radformation.com